NCT07130357

Brief Summary

This prospective multicenter randomized controlled trial evaluates the clinical efficacy of collagen scaffold augmentation in surgical repair for acute Achilles tendon ruptures. The study will enroll 48 adult participants randomly assigned to either the intervention group (surgical repair with collagen scaffold augmentation) or the control group (standard surgical repair without scaffold). The primary outcome is tendon function assessed using the VISA-A score, while secondary outcomes include tendon healing characteristics measured by ultrasound (thickness, neovascularity), calf muscle strength, ankle range of motion, and complication rates. Follow-up assessments will be conducted at 6 weeks, 3 months, 6 months, and 12 months post-surgery. The study aims to determine whether collagen scaffold augmentation enhances tendon healing and functional recovery compared to conventional repair methods, potentially offering a improved treatment approach for Achilles tendon injuries.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
21mo left

Started Dec 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
Dec 2025Dec 2027

First Submitted

Initial submission to the registry

August 12, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 19, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

December 25, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

March 25, 2026

Status Verified

March 1, 2026

Enrollment Period

2 years

First QC Date

August 12, 2025

Last Update Submit

March 22, 2026

Conditions

Keywords

Achilles Tendon RuptureCollagen Scaffold AugmentationRegenetenAchilles Tendon Rupture Repair

Outcome Measures

Primary Outcomes (1)

  • Victorian Institute of Sports Assessment (VISA-A)

    The primary outcome is the score of the Victorian Institute of Sports Assessment - Achilles (VISA-A) questionnaire, which is explicitly designed for Achilles tendon. VISA-A will be used to evaluate pain and symptom severity with activity in participants with Achilles tendon rupture. Chinese-speaking participants will complete the validated Chinese VISA-A questionnaire . The VISA-A questionnaire covers three domains associated with AT: pain, function, and sporting activities. A deterioration in self-reported pain, function and sporting activities is the critical reason patients with Achilles tendon rupture come for medical consultation. Improving questions covered in VISA-A is often the rehabilitation goal for these patients.

    6 weeks and 3, 6, 12 months after surgery

Secondary Outcomes (12)

  • Surgical complications

    During surgery

  • Foot and Ankle outcome scores (FAOS)

    6 weeks and 3, 6, 12 months

  • Ultrasound measure of tendon thickness

    6 weeks and 3, 6. 12 months

  • Ultrasound measurement of tendon neovascularity

    6 weeks and 3, 6 ,12 months

  • Ultrasound measurement of tendon elasticity

    6 weeks and 3, 6, 12 months

  • +7 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Participants in the intervention group will undergo Achilles tendon repair with Collagen Scaffold Augmentation. Upon diagnosis of an Achilles tendon rupture, the participant will receive a temporary slab and surgical repair will be scheduled, and the operation will be performed under general anaesthesia with the patient lying prone. The ruptured ends of the right Achilles tendon will be marked, and a 3 cm longitudinal skin incision will be made along the medial border of the tendon. A standardized end-to-end direct surgical repair using non-absorbable sutures in a 2-strand core in a krackow locking fashion will be performed. The bioinductive collagen scaffold will be placed over the repair site and secured with soft tissue anchors. The surgical site will be closed in layers using 3-0 vicryl and 4-0 ethilon. The patient will be discharged the following day and will follow a standardized rehabilitation plan by our physiotherapist. The rehabilitation is split into 4 phases: the protect

Device: Collagen ScaffoldProcedure: Achilles tendon repair

Control Group

ACTIVE COMPARATOR

Participants in the control group will undergo Achilles tendon repair using the same method as the intervention group, only without the additional collagen scaffold augmentation. The rehabilitation protocol will also be identical to the intervention group.

Procedure: Achilles tendon repair

Interventions

The bioinductive collagen scaffold will be placed over the repair site and secured with soft tissue anchors.

Intervention group

Upon diagnosis of an Achilles tendon rupture, the participant will receive a temporary slab and surgical repair will be scheduled, and the operation will be performed under general anaesthesia with the patient lying prone. The ruptured ends of the right Achilles tendon will be marked, and a 3 cm longitudinal skin incision will be made along the medial border of the tendon. A standardized end-to-end direct surgical repair using non-absorbable sutures in a 2-strand core in a krackow locking fashion will be performed. The surgical site will be closed in layers using 3-0 vicryl and 4-0 ethilon.

Control GroupIntervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Achilles tendon rupture.
  • Age \> 18 and able to provide written informed consent.

You may not qualify if:

  • Hypersensitive to bovine-derived materials.
  • Prior foot/ankle surgery or intervention within 1 year
  • Ongoing litigation regarding current injury
  • Active psychological or physical condition pre-empting participation, including psychosis, mental retardation, stroke.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prince of Wales Hospital

Shatin, New Territories, 000000, Hong Kong

RECRUITING

Central Study Contacts

Samuel K Ling, MBChB (CUHK), ChM (Edin), MRCS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

August 12, 2025

First Posted

August 19, 2025

Study Start

December 25, 2025

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

March 25, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations